Abstract
Repeated observations that the maximal response elicited by an agonist can be obtained when only a fraction of receptors are occupied has led to the concept of “spare receptors” (or “receptor reserve”). A large pool of “spare receptors” has been found in many peripheral tissues and partial agonists with substantial, but submaximal, intrinsic efficacy often produce maximal response (Nickerson 1956; Stephenson 1956; Ariens et al., 1960). The law of mass action relates fractional occupancy to ligand concentration and it follows that a lower agonist concentration will suffice to elicit a particular level of response the greater the excess of functional receptors (larger receptor reserve). In order to delineate the relationship between receptor occupancy and closely coupled physiologic responses at α2-adrenergic and dopaminergic autoreceptors, we have inactivated a portion of these receptors with the recently described irreversible antagonist N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) (Meller et al., 1985). This compound was found to dose-dependently inactivate central α2-adrenrgic and dopaminergic receptors in vivo.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Adler, C.H., Meller, E. and Goldstein, M. (1985). Recovery of alpha2-adrenoceptor binding and function after irreversible inactivation by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ). Eur. J. Pharmacol. 116, 1178–178.
Ariens, E.J., Van Rossum, J.M. and Koopman, P.C. ( 1960). Receptor reserve and threshold phenomena. Arch. Int. Pharmacodyn Ther. 127, 459–478.
Cambridge, D. (1981). UK-14,304, a potent and selective alpha2-agonist for the characterization of alpha-adrenoreceptor subtypes. Eur. J. Pharmacol. 72, 413–415.
Carlsson, A. (1983). Dopamine receptor agonists: intrinsic activity vs. state of receptor. J. Neur. Trans. 57, 309–315.
Clark, D., Hjorth, S. and Carlsson, A. (1985). Dopamine receptor agonists: mechanisms underlying autoreceptor selectivity. II. Theoretical considerations. J. Neur. Trans. 62, 171–207.
Frankhuyzen, A.L. and Mulder, A.H. (1982). A cumulative dose-response technique for the characterization of presynaptic receptors modulating [3H]noradrenaline release from rat brain slices. Eur. J. Pharmacol. 78., 91–97.
Furchgott, R.F. (1966). The use of beta-haloalkylamines in the differentiation of receptors and in the determination of dissociation constants of receptor-agonist complexes. Adv. Drug Res. 3, 21–55.
Goldstein, M., Helmer, E. and Fuxe, K. (1984). Effects of dopamine agonists on presynaptic normosensitive and on postsynaptic supersensitive DA receptors. IUPHAR 9th International Congress of Pharmacology, Abstr. 1155P.
Goldstein, M., Lieberman, A. and Battista, A.F. (1984). The therapeutic potential of centrally acting dopamine agonists. Trends in Pharmacol. Sci. 5, 227–230.
Mauger, J.P., Sladeczek, F. and Bockaert, J. (1982). Characteristics and metabolism of alpha1 adrenergic receptors in a nonfusing muscle cell line. J. Biol. Chem. 257, 875–879.
Meller, E., Bohmaker, K., Goldstein, M. and Friedhoff, A.J. (1985). Inactivation of D1 and D2dopamine receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo. J Pharm. Exp. Ther. 233, 656–662.
Meller, E., Helmer-Matyjek, E., Bohmaker, K., Adler, C.H., Friedhoff, A.J. and Goldstein, M. (1986). Receptor reserve at striatal dopamine autoreceptors: Implications for selectivity of dopamine agonists. Eur. J. Pharmacol. 123, 311–314.
Minneman, K.P. and Abel, P.W. (1984). Spare alpha1-adrenergic receptors and the potency of agonists in rat vas deferens. Mol. Pharmacol. 25., 56–62.
Nickerson, M. Receptor occupancy and tissue response. (1956). Nature 178,697–698.
Roth, R.H. (1979). Dopamine autoreceptors: pharmacology, function and comparison with post-synaptic dopamine receptors. Commun. Psychopharmacol. 3, 49.
Schoffelmeer, A.N.M., Hoorneman, E.M.D., Sminia, P. and Mulder, A.H. (1984). Presynaptic α2 and postsynaptic B-adrenoreceptor sensitivity in slices of rat neocortex after chronic treatment with various antidepressant drugs. Neuropharm. 23, 115–120.
Seyfried, CA., Fuxe, K., Wolf-H.P. and Agnati, L.D. (1982). Demonstration of a new type of dopamine receptor agonist: an indolyl-3-butylamine. Actions at intact versus supersensitive dopamine receptors in the rat forebrain. Acta Physiol. Scand. 116, 465–468,
Stephenson, R.P. (1956). A modification of receptor theory. Br. J. Pharmacol. 11:379–393.
Sugrue, M.F. (1983). Chronic antidepressant therapy and associated changes in central monoaminergic receptor functioning. Pharmacol. Ther. 21, 1–33.
Editor information
Editors and Affiliations
Copyright information
© 1987 The Wenner-Gren Center
About this chapter
Cite this chapter
Goldstein, M., Meller, E., Adler, C.H. (1987). Receptor Reserves at α2-adrenergic and Dopaminergic Autoreceptors. In: Fuxe, K., Agnati, L.F. (eds) Receptor-Receptor Interactions. Wenner-Gren Center International Symposium Series. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-08949-9_4
Download citation
DOI: https://doi.org/10.1007/978-1-349-08949-9_4
Publisher Name: Palgrave Macmillan, London
Print ISBN: 978-1-349-08951-2
Online ISBN: 978-1-349-08949-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)